BLFS Biolife Solutions Inc

BioLife Solutions Inc manufactures proprietary and generic cGMP biopreservation media products, generic formulations of blood stem cell freezing media products, custom product formulation packaging services and contract aseptic manufacturing formulation.

$38.63  +0.63 (1.66%)
As of 06/14/2021 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  11/24/1989
Outstanding shares:  40,390,175
Average volume:  229,265
Market cap:   $1,489,185,752
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    09062W204
ISIN:        US09062W2044
Sedol:      BJH08B2
Valuation   (See tab for details)
PE ratio:   -73.93
PB ratio:   6.12
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy